关注
Henrik Jespersen
Henrik Jespersen
Akershus University Hospital; University of gothenburg
在 oncology.gu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
H Jespersen, MF Lindberg, M Donia, EMV Söderberg, R Andersen, ...
Nature communications 8 (1), 707, 2017
1702017
Molecular profiling of driver events in metastatic uveal melanoma
J Karlsson, LM Nilsson, S Mitra, S Alsén, GV Shelke, VR Sah, ...
Nature communications 11 (1), 1894, 2020
1222020
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, ...
Nature communications 12 (1), 5155, 2021
1032021
HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice
EMV Forsberg, MF Lindberg, H Jespersen, S Alsén, RO Bagge, M Donia, ...
Cancer Research 79 (5), 899-904, 2019
992019
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
BO Einarsdottir, RO Bagge, J Bhadury, H Jespersen, J Mattsson, ...
Oncotarget 5 (20), 9609, 2014
732014
Lipids, curvature stress, and the action of lipid prodrugs: Free fatty acids and lysolipid enhancement of drug transport across liposomal membranes
H Jespersen, JH Andersen, HJ Ditzel, OG Mouritsen
Biochimie 94 (1), 2-10, 2012
542012
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
H Jespersen, R Olofsson Bagge, G Ullenhag, A Carneiro, H Helgadottir, ...
BMC cancer 19, 1-7, 2019
502019
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
BO Einarsdottir, J Karlsson, EMV Söderberg, MF Lindberg, ...
Cell Death & Disease 9 (8), 810, 2018
402018
Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models
L Ny, LY Rizzo, V Belgrano, J Karlsson, H Jespersen, L Carstam, ...
Annals of Oncology 31 (2), 266-273, 2020
362020
Real-world data on PD-1 inhibitor therapy in metastatic melanoma
A Arheden, J Skalenius, S Bjursten, U Stierner, L Ny, M Levin, ...
Acta Oncologica 58 (7), 962-966, 2019
312019
Effect of free fatty acids and lysolipids on cellular uptake of doxorubicin in human breast cancer cell lines
N Rasmussen, JH Andersen, H Jespersen, OG Mouritsen, HJ Ditzel
Anti-cancer drugs 21 (7), 674-677, 2010
302010
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases
H Jespersen, S Bjursten, L Ny, M Levin
The Lancet Oncology 19 (6), e327, 2018
252018
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma
VR Sah, J Karlsson, H Jespersen, MF Lindberg, LM Nilsson, L Ny, ...
Melanoma Research 32 (4), 241-248, 2022
152022
Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)
H Jespersen, RO Bagge, G Ullenhag, A Carneiro, H Helgadottir, ...
Annals of Oncology 30, v907, 2019
122019
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis
S Bjursten, A Pandita, Z Zhao, C Fröjd, L Ny, C Jensen, T Ullerstam, ...
Journal for Immunotherapy of Cancer 9 (7), 2021
112021
Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primary
RO Bagge, A Demir, J Karlsson, B Alaei-Mahabadi, BO Einarsdottir, ...
JCO precision oncology 2, 1-25, 2018
112018
Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial: study protocol for a randomized controlled trial
CJ Holmberg, D Katsarelias, H Jespersen, A Carneiro, NO Elander, ...
Acta Oncologica 60 (1), 52-55, 2021
62021
Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma
J Karlsson, LM Nilsson, EMV Forsberg, S Mitra, S Alsén, G Shelke, ...
bioRxiv, 742023, 2019
32019
Chemokine analysis in patients with metastatic uveal melanoma suggests a role for CCL21 signaling in combined epigenetic therapy and checkpoint immunotherapy
VR Sah, H Jespersen, J Karlsson, LM Nilsson, M Bergqvist, I Johansson, ...
Cancer Research Communications 3 (5), 884-895, 2023
12023
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in uveal melanoma
VR Sah, H Jespersen, J Karlsson, MF Lindberg, LM Nilsson, L Ny, ...
bioRxiv, 2021.02. 04.429575, 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–20